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STUDY

Analysis of Globule Types in Malignant Melanoma
Jin Xu, BS; Kapil Gupta, PhD; William V. Stoecker, MS, MD; Yamini Krishnamurthy; Harold S. Rabinovitz, MD;
Austin Bangert, BS; David Calcara, BS; Margaret Oliviero, ARNP; Joseph M. Malters, MD; Rhett Drugge, MD;
R. Joe Stanley, PhD; Randy H. Moss, PhD; M. Emre Celebi, PhD

Objective: To identify and analyze subtypes of glob-

ules based on size, shape, network connectedness,
pigmentation, and distribution to determine which
globule types and globule distributions are most
frequently associated with a diagnosis of malignant
melanoma.
Design: Retrospective case series of dermoscopy im-

ages with globules.
Setting: Private dermatology practices.
Participants: Patients in dermatology practices.
Intervention: Observation only.
Main Outcome Measure: Association of globule types

with malignant melanoma.

Results: The presence of large globules (odds ratio [OR],
5.25) and globules varying in size (4.72) or shape (5.37)
had the highest ORs for malignant melanoma among all
globule types and combinations studied. Classical globules (dark, discrete, convex, and 0.10-0.20 mm) had a
higher risk (OR, 4.20) than irregularly shaped globules
(dark, discrete, and not generally convex) (2.89). Globules connected to other structures were not significant
in the diagnosis of malignant melanoma. Of the different configurations studied, asymmetric clusters have the
highest risk (OR, 3.02).
Conclusions: The presence of globules of varying size
or shape seems to be more associated with a diagnosis
of malignant melanoma than any other globule type or
distribution in this study. Large globules are of particular importance in the diagnosis of malignant melanoma.
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ERMOSCOPY IS A NONINvasive imaging technique that uses optical
magnification with fluid
immersion or with crosspolarized lighting to allow better clinical
assessment of skin lesions.1 Dermoscopy
has been shown to improve diagnostic accuracy of pigmented lesions when used by
practitioners with formal training.2,3

CME available online at
www.jamaarchivescme.com
Dots and globules were defined together at a virtual dermoscopy consensus
meeting in 2000 as black, brown, round
to oval, various-sized structures regularly or irregularly distributed within a
melanocytic lesion.1 Dots and globules are
differentiated by size, with several studies 4-7 reporting that globules exceed
0.1 mm in diameter.
Brown and black globules seen in
melanocytic lesions must be distinguished from the blue-gray globules seen
in basal cell carcinoma.1 If the globules
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are present in a regular distribution, they
are indicative of a benign melanocytic
lesion. 1,4-6,8,9 If they are present in an
irregular (also called uneven,5 nonuniform,8 or haphazard4) distribution pattern, they are indicative of a malignant
melanoma.1,4-6,8,9 In addition, globules of
uneven size and shape are characteristic
of malignant melanoma.1,4-6,8,9
In most of the diagnostic studies that
measured sensitivity and specificity of dots
and globules, the 2 features were studied
together. The 2000 consensus meeting
about dermoscopy found that the presence of dots and globules in an irregular
distribution had a sensitivity of 75% and
a specificity of 64% in melanoma diagnosis.1 In a study of the 7-point checklist, Argenziano et al9 found a similar 73.7% sensitivity for irregular dots and globules, with
a higher specificity of 82.0%. However, Salopek et al10 could not confirm the importance of dots and globules in distinguishing early melanoma from atypical nevi.
The objective of this study was to identify and analyze subtypes of globules based
on size, shape, network connectedness,

WWW.ARCHDERMATOL.COM

©2009 American Medical Association. All rights reserved.
Downloaded From: http://jamanetwork.com/ by a Missouri S & T User on 07/26/2017

Globule or Distribution
Type
Globule Type∗

Diagram

Definition

a. Classical

Discrete, dark, generally convex and
of classical size, 0.10-0.20 mm

b. Large

Discrete, dark, 0.20-0.70 mm

c. Irregular

Discrete, dark, shape not classical,
not convex, has protrusions, 0.100.20 mm, general shape is not ovoid

d. Light

Lightly pigmented and discrete, any
shape, 0.05-0.70 mm

e. Small dot-globule variant†

Discrete, dark, and small (0.03-0.05 mm),
generally lack discernible shape

f. Connect-globule variant†

Not discrete; adjacent to or within other
dark structures, including pigment
network and structureless areas
(0.05-0.20 mm)

Distribution Type‡§
Eccentric

Overall unbalanced globule distribution;
the centroid of the globules is significantly
off center; it is closer to the edge of the
lesion than to the centroid of the lesion

Asymmetric clusters

A globule cluster (≥3 globules within
1 mm) is asymmetric if no cluster is
present on the opposite side of the
best axis of symmetry within the lesion

Peripheral rim

Outermost distribution, with globules at
or near the rim of the lesion and
distributed around a significant portion
of the lesion rim

Compound Globule Type§
Varying size

Lesion has globules with size differing
by at least a factor of 2

Varying shape

Lesion has ≥1 classical or 1 large globule
(type a or type b) and ≥1 irregular globule
(type c)

Varying pigmentation

Lesion has ≥1 light globule of type d and
≥1 classical, large, or irregular globule of
type a, b, or c

Figure 1. Definitions of globule and globule distribution types. *Globule
types are illustrated. †Connected globular structures and dot-like globular
structures, although not generally considered globules, are included in this
study to examine their association with melanoma. ‡A minimum of
3 globules is needed for any globule distribution assignment. §Only
nonvariant globules are considered in globule distribution and compound
globule assignments.

pigmentation, and distribution to determine which globule types and globule distributions are most frequently
associated with a diagnosis of malignant melanoma.
METHODS
The image set used in this study consists of 600 digital dermoscopy images of melanocytic lesions, 325 of which had
globules. This image set included 175 invasive malignant
melanomas, 319 dysplastic nevi with mild or moderate atypia,
and 106 nevocellular nevi without atypia. Only invasive melanomas were included in this study. One hundred twenty-two
of the malignant melanoma images were obtained from a prepublication version of the American Academy of Dermatology
DVD on Dermoscopy, edited by Harold S. Rabinovitz et al.
Images of 53 malignant melanomas and the 2 classes of nevi
were acquired at 3 clinics (The Dermatology Center, Rolla,
Missouri; Skin and Cancer Associates, Plantation, Florida; and
Sheard and Drugge, PC, Stamford, Connecticut). The images

had a typical resolution of 1024 ⫻ 768 pixels. Images were
acquired via 1 of 2 contact dermoscopy instruments using a
glass plate with a fluid interface (Dermaphot; Heine Optotechnik GMBH and Co, Herrsching, Germany; or DermLite Fluid;
3Gen, San Juan Capistrano, California). The Phelps County
Regional Medical Center Institutional Review Board, Rolla,
Missouri, approved this research, and each subject or subject’s
parent or guardian signed a consent form for this research. All
melanomas were biopsied and examined by a dermatopathologist, and all benign lesions were biopsied or followed up
and determined to have no change. The median Breslow
thickness for those melanomas that had this measurement
available was 0.35 mm.
For all 325 images of pigmented lesions with globules from
these image sets, students ( J.X., Y.K., A.B., and D.C.) and a dermatologist (W.V.S.) identified globules and variant globulelike structures. These globules and variant structures were identified as 1 of the following 6 types (Figure 1): (a) classical (dark
[heavily pigmented], discrete globules with convex shape, 0.100.20 mm), (b) large (dark, discrete globules of varying shape,
0.20-0.70 mm), (c) irregular (dark, discrete globules with irregular nonconvex shape, 0.10-0.20 mm), (d) light (discrete
convex globules with light coloring, 0.05-0.70 mm), (e) small
dot-globule variant (dark, discrete globules, 0.03-0.05 mm), or
(f ) connect-globule variant (dark, nondiscrete globules connected to a pigment network or a blotch, 0.05-0.20 mm). The
classical globule sizes were classified as 0.03 to 0.05 mm, 0.05
to 0.10 mm, and 0.10 to 0.20 mm in diameter. Globule size
was measured as the greatest diameter, determined using the
known ⫻10 magnification of the images. We did not attempt
to separate black globules from brown globules, as is sometimes done in the literature, because we found that few globules have pigmentation so dark as to be considered black and
because such cases appear against a dark background. Globule size for each optical platform was calibrated using images
that contained ruler scales within the images. Using these images with ruler scales and the known resolution of the images
in pixels, we determined the upper and lower limits of pixel
diameter for each category of globule size. For example, fully
zoomed images (DermLite Fluid) from the clinics were calibrated at 0.01 mm per pixel; images that were not fully zoomed
were calibrated by the scale visible on the images. Other images (Dermaphot) from the atlas were calibrated at 0.0125 mm
per pixel. In the past, globule shape has been defined as round
or oval, but globules of pigmented lesions commonly have a
blob shape such as an imperfect egg shape or rounded trapezoid shape, as shown in Figures 2, 3, 4, 5, and 6 (the green
globules are considered of regular shape). Therefore, regular
globule shape was assigned only if the globule outline was
rounded and generally convex. Otherwise, globules were classified as irregular. Elongation was the most common characteristic of irregular globules in our set of lesions. Other globule types are defined in Figure 1. Figures 2 through 6 show
examples of the different globule types in benign and malignant nevocellular lesions. The presence or absence of each globule type was recorded in a database.
Three globule distribution characteristics were scored as
present or absent, as summarized in Figure 1. The first globule distribution type, eccentric, is defined as an overall unbalanced globule distribution, shown in Figures 2 and 5. The second globule distribution type, asymmetric clusters, is defined
as a group of 3 or more globules in an unbalanced position, as
shown in Figures 2, 4, and 5. The third globule distribution
type, peripheral rim, is defined as an outermost distribution,
with globules at or near the rim of the lesion and distributed
around a significant portion of the lesion, as shown in Figures 4
and 6. Some images may have more than 1 distribution type,
as shown in Figure 5 (eccentric and asymmetric clusters). Some
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Figure 2. Malignant melanoma with globules of different sizes and shapes. The globule distribution type is eccentric and shows asymmetric clusters but no
peripheral rim. Note that globules marked with green are not necessarily perfectly round or oval but are generally convex. The lesion outline used in determining
distribution type is shown in the inset at center. Green indicates classical; red, irregular; yellow, light; lavender, small dot-globule variant; light blue, large; and
blue, connect-globule variant.

Figure 3. Benign nevocellular nevus with regularly distributed globules. The globule distribution type is not peripheral rim, not eccentric, and is without
asymmetric clusters. Note that these benign globules are not perfectly round or oval.

Figure 4. Benign nevocellular nevus. The globule distribution type is not eccentric but has a peripheral rim and asymmetric clusters. Note that many of these
benign globules are not perfectly round or oval.

images may have none of the distribution types, as shown in
Figure 3. Figure 4 has 2 small asymmetric clusters, although
the entire distribution is symmetric around the major axis of
the lesion; therefore, the distribution type was scored as asym-

metric clusters. No globule distribution type was assigned unless 3 or more globules were present and most of the lesion border was present. Only nonvariant globules were used in
distribution type assessments.
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Figure 5. Malignant melanoma. The globule distribution type is eccentric and includes asymmetric clusters, but there is no peripheral rim.

Figure 6. Malignant melanoma. Although the peripheral rim is present in this lesion, other signs of malignant melanoma (blue-gray veil and irregular pigment
network) can be seen in the left upper quadrant. Dark globules of varying size and shape are present at the 12-o’clock position.

The assessment of global distribution type (eccentric, asymmetric clusters, or peripheral rim) was made independently by
2 dermatologists (W.V.S. and J.M.M.), who achieved consensus on any differing assessments. These dermatologists used
the following definitions for the distribution types. Eccentric
types have a distribution with the globule centroid (center of
all globules weighted by area) closer to the edge of the lesion
than to the center of the lesion. A cluster is a discrete group of
3 or more globules within 1 mm and is asymmetric if no cluster is present on the opposite side of the best axis of symmetry
for the lesion. The peripheral rim distribution was assigned only
to those lesions with globules at or near the lesion rim and distributed around a significant portion of the lesion rim. To minimize the likelihood that distribution type assessments were affected by knowledge of the diagnosis, distribution types were
determined by overlaying globule images on the lesion outlines shown in Figure 2 (inset).
For the globule data gathered, sensitivity, specificity, and
odds ratios (ORs) were calculated using the individual features. P values were computed from the 2 distribution using
the Wald 2 value (uncorrected Pearson product moment
correlation). Sensitivity, specificity, positive predictive value,
and ORs were calculated as follows: Sensitivity = true positive / (true positive ⫹ false negative). Specificity = true negative / (false positive ⫹ true negative). Positive Predictive

Value = true positive / (true positive ⫹ false positive).11 Odds
Ratios = (true positive ⫻ true negative) / (false negative ⫻ false
positive).
RESULTS

Of 175 malignant melanomas, 112 lesions (64.0%) had
globules of any type. Of 425 benign nevi, 213 (50.1%)
had globules of any type. Therefore, the OR for malignant melanoma among globules of any type is 1.77, 1.80
if variant globules are not considered (P⬍.001 for both).
One hundred fifty-four of 319 dysplastic nevi (48.3%)
and 60 of 106 nevocellular nevi (56.6%) had at least 1
type of globule. Every malignant melanoma with globules had at least 1 nonvariant type of globule, so expanding the definition of globules to include the connectglobule variant or small dot-globule variant adds nothing
to the sensitivity of globule presence for malignant melanoma diagnosis.
Statistics for the various globule and globule distribution types identified in the study are given in Figure 7.
The OR estimate for malignant melanoma for any der-
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Globule or
Distribution
Type

Diagram

Odds Ratio
(95% Confidence
Interval)

P Value Sensitivity, Specificity,
%
%

b. Unusually
large
c. Irregular

4.20 (2.87-6.15)

<.001

5.25 (2.95-9.31)

<.001

2.89 (2.01-4.17)

<.001

50

21

51

81

95

74

4.5

0.8

4.0

0.7

3.5

0.6

3.0

0.5

2.5

0.4

2.0

0.1
d. Light

1.98 (1.38-2.83)

<.001

47

69

1.5

0.3
0.2

Sensitivity
Specificity
Odds Ratio

1.0
0.5
0.0

0.0
0.03

e. Small
dot-globule
variant

1.54 (1.80-2.19)

.02

51

60

f. Connectglobule
variant

0.85 (0.56-1.72)

.49

23

73

Distribution
Type

Odds Ratio

a. Classical

Sensitivity and Specificity

Globule
Type

0.9

0.05

0.10

Globule Diameter, mm

Figure 8. Statistics on various lower limits of globule sizes calculated from
globule and globule distribution types.

Eccentric

1.94 (1.17-3.21)

<.001

17

90

Asymmetric
clusters

3.02 (2.08-4.39)

<.001

47

77

0.97 (0.22-4.39)

.79

01

99

Varying size

4.72 (3.23-6.87)

<.001

52

81

Varying shape

5.37 (3.54-8.16)

<.001

42

88

bution type. Knowledge of the diagnosis probably led to
bias in distribution type assignment for these subjective
measures. When only lesion outlines were used, the OR
decreased to 1.94 for the eccentric distribution type and
increased to 3.02 for asymmetric clusters distribution
type, which suggests bias in distribution type assignments when the original image is used. The 2 observers
disagreed on 9.8% of the eccentric distribution type
assignments and on 12.9% of the asymmetric clusters
distribution type assignments before consensus was
reached using the definitions described in the “Methods” section.

Varying
pigmentation

2.71 (1.87-3.93)

<.001

45

77

COMMENT

Peripheral rim

Compound
Globule
Type

Figure 7. Statistics for globule and globule distribution types.

moscopy feature is defined as the ratio of 2 odds obtained from these data (the odds for melanoma with the
feature divided by the odds for melanoma without the
feature). The highest OR for malignant melanoma of any
single globule type, 5.25, was obtained for large, dark,
discrete globules (ⱖ0.20 mm). The second highest OR,
4.20, was obtained for classical globules (dark, discrete,
convex globules, 0.10-0.20 mm). This OR falls to 2.41
and 2.24 for successively lower limits of globule sizes of
0.05 mm and 0.03 mm, respectively, as shown in
Figure 7.
Of the globule and globule distribution types, globules varying in size (OR, 4.72) and shape (OR, 5.37) had
the highest ORs for malignant melanoma (Figure 8).
Light globules and the small dot-globule variant had ORs
of less than 2. The connect-globule variant was not found
to be statistically significant. Only 7 lesions (2 malignant melanomas and 5 benign lesions) in our study had
a peripheral rim distribution type, too few lesions for significance. Both cases of malignant melanoma with a peripheral rim distribution type had other important indicators of melanoma, as shown in Figure 6.
When the original lesion images were used, the ORs
for malignant melanoma were 4.80 for the eccentric distribution type and 2.71 for asymmetric clusters distri-

Even with dermoscopy, the differentiation of early malignant melanoma from benign pigmented lesions remains a difficult challenge. Of all dermoscopic findings,
dots and globules that are of irregular size, shape, and
distribution have been found to be among the most important dermoscopic structures to aid in this discrimination.1,4-9,11,12 Annessi et al8 analyzed dots and globules
separately and found irregular, nonuniform globules
(globules varying in size and shape that had nonuniform distribution) to be among the 6 most sensitive and
specific features for the identification of thin melanoma. In that study, nonuniformity in distribution alone
had a higher positive predictive value than irregularity
in size or shape alone, although both features were needed
to achieve statistical significance. These findings are summarized by the clinical rule that “[m]elanomas have globules that are uneven in size and shape and most important, are also unevenly distributed.”5(p238)
We studied globules of varying size, differing shape,
and uneven (eccentric) distribution type separately. In
our study, all 3 categories achieved significance in melanoma discrimination, with size and shape variations
achieving greater melanoma discrimination than uneven distribution. The uneven distribution patterns are
the most subjective of all of the features studied. The observers found difficulty in determining eccentric distribution type, especially in borderline cases, because of difficulty in determining lesion and globule centroids.
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Statistics obtained for 3 lower limits of globule sizes
(Figure 8) show a higher OR for the classical lower limit
of 0.10 mm than for 0.05 mm or 0.03 mm. Some support for considering globules smaller than 0.10 mm is
found in the study by Scope et al,13 in which aggregates
of bright cells as small as 0.05 mm on confocal microscopy were correlated with globules that were barely detectable on dermoscopy. Therefore, a lower limit for globule size of approximately 0.05 mm could be proposed.
Inclusion of smaller globules adds the benefit of greater
size range. In practice, measurement of globule size is
not feasible. An alternative definition of the lower globule size limit could be applied, namely, that globules are
large enough to have perceptible shape. This definition
has limitations because perception of globule shape can
vary with the dermoscopy platform used.
Only 55 of 325 images had globules larger than 0.20
mm. The largest globule that we observed was 0.66 mm.
In our study, an empiric upper limit cutoff of 0.70 mm
was used to define large globules. We found that 4.5%
of benign lesions had globules between 0.20 and 0.70 mm.
In contrast, 20.3% of malignant melanomas had globules in this size range.
In addition to the retrospective nature of the study,
other limitations are the lack of blinding of diagnosis
among observers, the high ratio of malignant melanomas to benign lesions, and the likelihood of errors in globule determination and marking. The possibilities of errors in marking the globules and diagnostic bias were kept
to a minimum by the 3-pass technique of an undergraduate student (Y.K. or A.B.) marking the globules, corrected by a medical student ( J.X. or D.C.), and then corrected by a dermatologist (W.V.S.) experienced in
dermoscopy, who adjusted the students’ markings for each
lesion. The students were less influenced by diagnosis
in their markings and had less bias in distribution type
assignments. The dermatologist corrected less than 15%
of the individual globule markings or database entries.
The technique of overlaying globule images on the lesion outlines was used to delineate the types of globules
and to allow efficient checking of globule classification.
Lesion outlines were used for globule distribution typing to reduce the possibility of bias in assessment, but
the possibility of bias remained because of lesion outline recognition.
The lesions included in the study were obtained from
3 private dermatology practices in the United States and
are believed to be representative of such lesions but may
not be generalizable to lesions seen in academic settings
or in other geographic locations. The percentage of lesions from our series that had globules was similar to that
found in university studies in other locations. Steiner et
al14 found 60.7% of nevocellular nevi, 55.0% of dysplastic nevi, and 43.8% of malignant melanomas to have
brown globules compared with our totals of 56.6% of nevocellular nevi, 48.3% of dysplastic nevi, and 64.0% of
malignant melanomas that had globules and related structures. Menzies et al15 found 60% and 94% of malignant
melanomas to have black and brown dots or globules,
respectively. The methods of counting globules in these
studies are not strictly comparable. The high ratio of malignant melanomas to benign lesions in our study has the

disadvantage of a higher ratio than is seen in other settings but has the advantage of a greater number of melanomas to allow better characterization of globules among
these lesions.
Another caveat is that globules seem to be less common in earlier melanomas. We have noted fewer globules
in the invasive melanomas observed during the past few
years. This is in agreement with the observation by Salopek et al,10 who did not find that dots or globules are important in distinguishing early melanoma from atypical nevi.
Nevi with a global cobblestone or globular pattern were
scored as lacking globules. There was a potential for confusion of globules with this global cobblestone pattern
in nevi. The nevi with a globular pattern usually have
larger globules, and they are more regular and less discrete, as found by Hofmann-Wellenhof et al.16 Using the
requirement that globules should be discrete or connected to other structures, we found no globules on the
6 nevi with the global cobblestone pattern in our lesion
set.
In summary, for this series of lesions with globules,
features that are most predictive of malignant melanoma are the following: heavily pigmented (dark), discrete, convex globules; globules exceeding 0.20 mm in
diameter; and the presence of globules of varying size or
shape. The presence of globules varying in shape had the
highest OR for malignant melanoma among all globule
types and combinations studied. Asymmetric clusters seem
to be more frequently associated with malignant melanoma than eccentric globules. The connect-globule variant did not reach statistical significance for diagnosing
malignant melanoma.
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Archives Web Quiz Winner

C

ongratulations to the winner of our August quiz,
Abhilasha Williams, MBBS, MD, Department of
Dermatology, Christian Medical College, Vellore, India.
The correct answer to our August challenge was
lichen striatus. For a complete discussion of this case, see
the Off-Center Fold section in the September Archives
(Ramos-Herberth F, Bishop K, Kim J. Linear pruritic eruption with onychodystrophy in a 1-year-old girl. Arch
Dermatol. 2009;145[9]:1053-1058).
Be sure to visit the Archives of Dermatology Web site
(http://www.archdermatol.com) to try your hand at the
interactive quiz. We invite visitors to make a diagnosis
based on selected information from a case report or other
feature scheduled to be published in the following month’s
print edition of the Archives. The first visitor to e-mail
our Web editors with the correct answer will be recognized in the print journal and on our Web site and will
also receive a free copy of The Art of JAMA II.
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